Diabetes vaccine gives promising results in a genetic subgroup
GMC backs call for a mandatory register of doctors’ interests
24 May 2021Should kids get a COVID-19 vaccination?
24 May 2021Diabetes vaccine gives promising results in a genetic subgroup
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
